Format

Send to

Choose Destination
See comment in PubMed Commons below
Cancer Res. 2006 Dec 15;66(24):11576-9.

Activated checkpoint kinase 2 provides a survival signal for tumor cells.

Author information

1
Department of Cancer Biology, University of Massachusetts Medical School, Worcester, Massachusetts 01605, USA.

Abstract

Tumor cells often become resistant to DNA damage-based therapy; however, the underlying mechanisms are not yet understood. Here, we show that tumor cells exposed to DNA damage counteract cell death by releasing the antiapoptotic protein, survivin, from mitochondria. This is independent of p53, and requires activated checkpoint kinase 2 (Chk2), a putative tumor suppressor. Molecular or genetic targeting of Chk2 prevents the release of survivin from mitochondria, enhances DNA damage-induced tumor cell apoptosis, and inhibits the growth of resistant in vivo tumors. Therefore, activated Chk2 circumvents its own tumor-suppressive functions by promoting tumor cell survival. Inhibiting Chk2 in combination with DNA-damaging agents may provide a rational approach for treating resistant tumors.

PMID:
17178848
DOI:
10.1158/0008-5472.CAN-06-3095
[Indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire
    Loading ...
    Support Center